Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 486,277 | 550,238 | 516,514 | 521,656 | 485,121 |
| Cost of Goods | 207,695 | 238,332 | 220,338 | 228,520 | 207,510 |
| Gross Profit | 278,582 | 311,906 | 296,176 | 293,136 | 277,611 |
| Operating Expenses | 224,911 | 216,223 | 222,592 | 225,470 | 211,003 |
| Operating Income | 54,366 | 96,015 | 73,922 | 68,186 | 67,118 |
| Interest Expense | 13,196 | 11,987 | 12,341 | 12,041 | 16,766 |
| Other Income | 5,009 | -34 | -5,808 | 1,674 | -2,091 |
| Pre-tax Income | 46,179 | 83,994 | 55,773 | 57,819 | 48,261 |
| Income Tax | 15,235 | 24,003 | 9,911 | 17,797 | 15,323 |
| Net Income Continuous | 30,944 | 59,991 | 45,862 | 40,022 | 32,938 |
| Minority Interests | -61 | -38 | -35 | -26 | -101 |
| Net Income | $31,005 | $60,029 | $45,897 | $40,048 | $33,039 |
| EPS Basic Total Ops | 1.10 | 2.15 | 1.63 | 1.43 | 1.18 |
| EPS Basic Continuous Ops | 1.10 | 2.14 | 1.63 | 1.43 | 1.18 |
| EPS Diluted Total Ops | 1.09 | 2.11 | 1.61 | 1.41 | 1.16 |
| EPS Diluted Continuous Ops | 1.08 | 2.10 | 1.61 | 1.40 | 1.16 |
| EBITDA(a) | $54,366 | $96,015 | $73,922 | $68,186 | $67,118 |